Changes in the Expression of Long Non-Coding RNA SDMGC and Its Target Gene, TRIM16, in Patients with Gastric Cancer

Mina Seifi Inallou1, Reza Safaralizadeh2, Ali Rajabi1

  • 1Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran.

Abstract

Insights

Gastric cancer (GC) shows increased long non-coding RNA SDMGC and decreased TRIM16 expression in Iranian patients. SDMGC acts as an oncogene, while TRIM16 functions as a tumor suppressor in GC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Gastric cancer (GC) is a prevalent malignancy with high mortality.
  • Long non-coding RNA SDMGC is implicated as an oncogene, potentially regulating the tumor suppressor gene TRIM16.
  • Both SDMGC and TRIM16 are involved in GC progression, including tumorigenesis, invasion, and metastasis.

Purpose of the Study:

  • To investigate the association between SDMGC and TRIM16 expression and GC susceptibility.
  • To examine the correlation of SDMGC and TRIM16 with clinicopathological characteristics of GC patients.
  • To evaluate the diagnostic potential of SDMGC and TRIM16 as biomarkers for GC.

Main Methods:

  • Quantitative reverse transcriptase (qRT)-PCR was used to measure SDMGC and TRIM16 expression levels.
  • Expression levels were compared between 100 GC tissues and adjacent non-tumor tissues.
  • Statistical analyses included Mann-Whitney U test, correlation tests, and receiver operating curve (ROC) analysis.

Main Results:

  • Significant overexpression of SDMGC and downregulation of TRIM16 were observed in GC tissues compared to normal tissues (P=0.005 and P=0.009).
  • No significant association was found between SDMGC or TRIM16 expression and clinicopathological variables.
  • SDMGC and TRIM16 exhibited poor biomarker potency for GC diagnosis, despite a small positive correlation between their expression levels.

Conclusions:

  • SDMGC expression is increased, and TRIM16 expression is decreased in GC patients from the Iranian population.
  • SDMGC demonstrates a tumor-accelerative function, whereas TRIM16 exhibits a tumor-suppressing role in GC.
  • Further research may elucidate the precise molecular mechanisms underlying their roles in gastric carcinogenesis.